COVID-19 Impact on Global Macular Degeneration Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 96 pages | ID: C7550FF19B8EEN
QYResearch

Abstracts

This report focuses on the global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Degeneration Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bausch Health Companies
• Allergan
• Novartis
• Pfizer
• Bayer
• Roche
• Sanofi
• Santen Pharmaceuticals
• Regeneron Pharmaceuticals
• Kanghong Pharma

Market segment by Type, the product can be split into

• Lucentis
• Eylea
• Avastin
• Others

Market segment by Application, split into

• Hospitals
• Eye Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Macular Degeneration Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Macular Degeneration Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Macular Degeneration Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Lucentis
  1.4.3 Eylea
  1.4.4 Avastin
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Macular Degeneration Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Eye Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Macular Degeneration Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Macular Degeneration Treatment Industry
    1.6.1.1 Macular Degeneration Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Macular Degeneration Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Macular Degeneration Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Macular Degeneration Treatment Market Perspective (2015-2026)
2.2 Macular Degeneration Treatment Growth Trends by Regions
  2.2.1 Macular Degeneration Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Macular Degeneration Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Macular Degeneration Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Macular Degeneration Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Macular Degeneration Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Macular Degeneration Treatment Players by Market Size
  3.1.1 Global Top Macular Degeneration Treatment Players by Revenue (2015-2020)
  3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Macular Degeneration Treatment Market Concentration Ratio
  3.2.1 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Macular Degeneration Treatment Revenue in 2019
3.3 Macular Degeneration Treatment Key Players Head office and Area Served
3.4 Key Players Macular Degeneration Treatment Product Solution and Service
3.5 Date of Enter into Macular Degeneration Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Macular Degeneration Treatment Historic Market Size by Type (2015-2020)
4.2 Global Macular Degeneration Treatment Forecasted Market Size by Type (2021-2026)

5 MACULAR DEGENERATION TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Macular Degeneration Treatment Market Size by Application (2015-2020)
5.2 Global Macular Degeneration Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Macular Degeneration Treatment Market Size (2015-2020)
6.2 Macular Degeneration Treatment Key Players in North America (2019-2020)
6.3 North America Macular Degeneration Treatment Market Size by Type (2015-2020)
6.4 North America Macular Degeneration Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Macular Degeneration Treatment Market Size (2015-2020)
7.2 Macular Degeneration Treatment Key Players in Europe (2019-2020)
7.3 Europe Macular Degeneration Treatment Market Size by Type (2015-2020)
7.4 Europe Macular Degeneration Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Macular Degeneration Treatment Market Size (2015-2020)
8.2 Macular Degeneration Treatment Key Players in China (2019-2020)
8.3 China Macular Degeneration Treatment Market Size by Type (2015-2020)
8.4 China Macular Degeneration Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Macular Degeneration Treatment Market Size (2015-2020)
9.2 Macular Degeneration Treatment Key Players in Japan (2019-2020)
9.3 Japan Macular Degeneration Treatment Market Size by Type (2015-2020)
9.4 Japan Macular Degeneration Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Macular Degeneration Treatment Market Size (2015-2020)
10.2 Macular Degeneration Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Macular Degeneration Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Macular Degeneration Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Macular Degeneration Treatment Market Size (2015-2020)
11.2 Macular Degeneration Treatment Key Players in India (2019-2020)
11.3 India Macular Degeneration Treatment Market Size by Type (2015-2020)
11.4 India Macular Degeneration Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Macular Degeneration Treatment Market Size (2015-2020)
12.2 Macular Degeneration Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Macular Degeneration Treatment Market Size by Type (2015-2020)
12.4 Central & South America Macular Degeneration Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bausch Health Companies
  13.1.1 Bausch Health Companies Company Details
  13.1.2 Bausch Health Companies Business Overview and Its Total Revenue
  13.1.3 Bausch Health Companies Macular Degeneration Treatment Introduction
  13.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2015-2020))
  13.1.5 Bausch Health Companies Recent Development
13.2 Allergan
  13.2.1 Allergan Company Details
  13.2.2 Allergan Business Overview and Its Total Revenue
  13.2.3 Allergan Macular Degeneration Treatment Introduction
  13.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.2.5 Allergan Recent Development
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Macular Degeneration Treatment Introduction
  13.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.3.5 Novartis Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Macular Degeneration Treatment Introduction
  13.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 Bayer
  13.5.1 Bayer Company Details
  13.5.2 Bayer Business Overview and Its Total Revenue
  13.5.3 Bayer Macular Degeneration Treatment Introduction
  13.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.5.5 Bayer Recent Development
13.6 Roche
  13.6.1 Roche Company Details
  13.6.2 Roche Business Overview and Its Total Revenue
  13.6.3 Roche Macular Degeneration Treatment Introduction
  13.6.4 Roche Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.6.5 Roche Recent Development
13.7 Sanofi
  13.7.1 Sanofi Company Details
  13.7.2 Sanofi Business Overview and Its Total Revenue
  13.7.3 Sanofi Macular Degeneration Treatment Introduction
  13.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.7.5 Sanofi Recent Development
13.8 Santen Pharmaceuticals
  13.8.1 Santen Pharmaceuticals Company Details
  13.8.2 Santen Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Introduction
  13.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.8.5 Santen Pharmaceuticals Recent Development
13.9 Regeneron Pharmaceuticals
  13.9.1 Regeneron Pharmaceuticals Company Details
  13.9.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Introduction
  13.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.9.5 Regeneron Pharmaceuticals Recent Development
13.10 Kanghong Pharma
  13.10.1 Kanghong Pharma Company Details
  13.10.2 Kanghong Pharma Business Overview and Its Total Revenue
  13.10.3 Kanghong Pharma Macular Degeneration Treatment Introduction
  13.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2015-2020)
  13.10.5 Kanghong Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Macular Degeneration Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Macular Degeneration Treatment Revenue
Table 3. Ranking of Global Top Macular Degeneration Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lucentis
Table 6. Key Players of Eylea
Table 7. Key Players of Avastin
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Macular Degeneration Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Macular Degeneration Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Macular Degeneration Treatment Players to Combat Covid-19 Impact
Table 14. Global Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Macular Degeneration Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Macular Degeneration Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Macular Degeneration Treatment Market Share by Regions (2015-2020)
Table 18. Global Macular Degeneration Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Macular Degeneration Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Macular Degeneration Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Macular Degeneration Treatment Players
Table 25. Global Macular Degeneration Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Macular Degeneration Treatment Market Share by Players (2015-2020)
Table 27. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Macular Degeneration Treatment as of 2019)
Table 28. Global Macular Degeneration Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Macular Degeneration Treatment Product Solution and Service
Table 31. Date of Enter into Macular Degeneration Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Macular Degeneration Treatment Market Size Share by Type (2015-2020)
Table 35. Global Macular Degeneration Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Macular Degeneration Treatment Market Size Share by Application (2015-2020)
Table 37. Global Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Macular Degeneration Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 41. North America Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 43. North America Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 47. Europe Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 49. Europe Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 53. China Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 55. China Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 59. Japan Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 61. Japan Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 65. Southeast Asia Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 71. India Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 73. India Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Macular Degeneration Treatment Market Share (2019-2020)
Table 77. Central & South America Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 81. Bausch Health Companies Company Details
Table 82. Bausch Health Companies Business Overview
Table 83. Bausch Health Companies Product
Table 84. Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 85. Bausch Health Companies Recent Development
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Product
Table 89. Allergan Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 90. Allergan Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Product
Table 104. Bayer Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 105. Bayer Recent Development
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Product
Table 109. Roche Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 110. Roche Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Product
Table 114. Sanofi Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 115. Sanofi Recent Development
Table 116. Santen Pharmaceuticals Business Overview
Table 117. Santen Pharmaceuticals Product
Table 118. Santen Pharmaceuticals Company Details
Table 119. Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 120. Santen Pharmaceuticals Recent Development
Table 121. Regeneron Pharmaceuticals Company Details
Table 122. Regeneron Pharmaceuticals Business Overview
Table 123. Regeneron Pharmaceuticals Product
Table 124. Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 125. Regeneron Pharmaceuticals Recent Development
Table 126. Kanghong Pharma Company Details
Table 127. Kanghong Pharma Business Overview
Table 128. Kanghong Pharma Product
Table 129. Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 130. Kanghong Pharma Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Macular Degeneration Treatment Market Share by Type: 2020 VS 2026
Figure 2. Lucentis Features
Figure 3. Eylea Features
Figure 4. Avastin Features
Figure 5. Others Features
Figure 6. Global Macular Degeneration Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Eye Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Macular Degeneration Treatment Report Years Considered
Figure 11. Global Macular Degeneration Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Macular Degeneration Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Macular Degeneration Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Macular Degeneration Treatment Market Share by Players in 2019
Figure 16. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Macular Degeneration Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Macular Degeneration Treatment Revenue in 2019
Figure 18. North America Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bausch Health Companies Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 27. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 33. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bayer Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 39. Santen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Santen Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 41. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 43. Kanghong Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Kanghong Pharma Revenue Growth Rate in Macular Degeneration Treatment Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed